Genetic association of DLG5 R30Q with familial and sporadic inflammatory bowel disease in men

Disease Markers

Volumn 27, Issue 5, 2009, Pages 193-201

  Lin, Z ^a   Poritz, L ^a   Franke, A ^b   Li, T Y ^c   Ruether, A ^b   Byrnes, K A ^a   Wang, Y ^a   Gebhard, A W ^a   MacNeill, C ^a   Thomas, N J ^a   R Wu, ^a   Schreiber, S ^b   Koltun, Walter A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KIEL   (Germany)

^c Total Health Management and Technology Inc ^*  (United States)

Author keywords

DLG5 R30Q; Familial IBD registry; Genetic association; Inflammatory bowel disease; Male specific

Indexed keywords

DLG5 KINASE; GLYCINE; GUANYLATE KINASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FAMILIAL INFLAMMATORY BOWEL DISEASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGISTER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SPORADIC INFLAMMATORY BOWEL DISEASE; ULCERATIVE COLITIS; UNITED STATES;

EID: 77249166049     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/167534     Document Type: Article

References (44)

1. R.K. Russell, E.R. Nimmo and J. Satsangi, Molecular genetics of Crohn's disease, Curr Opin Genet Dev 14(3) (2004), 264-270.
2. R.K. Russell, D.C. Wilson and J. Satsangi, Unravelling the complex genetics of inflammatory bowel disease, Arch Dis Child 89(7) (2004), 598-603.
3. S. Schreiber, P. Rosenstiel, M. Albrecht et al., Genetics of Crohn disease, an archetypal inflammatory barrier disease, Nature Reviews Genetics 6(5) (2005), 376-388. (Pubitemid 40577181)
4. M. Orholm, V. Binder, T.I. Sorensen et al., Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study, Scandinavian Journal of Gastroenterology 35(10) (2000), 1075-1081.
5. C. Tysk, E. Lindberg, G. Jarnerot et al., Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking, Gut 29(7) (1988), 990-996.
6. M. Peeters, H. Nevens, F. Baert et al., Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics.[see comment], Gastroenterology 111(3) (1996), 597-603.
7. J. Satsangi, C. Grootscholten, H. Holt et al., Clinical patterns of familial inflammatory bowel disease, Gut 38(5) (1996), 738-741. (Pubitemid 26167483)
8. C.O. Elson, Y. Cong, V.J. McCracken et al., Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota, Immunol Rev 206 (2005), 260-276.
9. J.P. Hugot, M. Chamaillard, H. Zouali et al., Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease, Nature 411(6837) (2001), 599-603.
10. Y. Ogura, D.K. Bonen, N. Inohara et al., Aframeshift mutation in NOD2 associated with susceptibility to Crohn's disease, Nature 411(6837) (2001), 603-606.
11. J.D. Rioux, M.J. Daly, M.S. Silverberg et al., Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease, Nat Genet 29(2) (2001), 223-228.
12. M. Stoll, B. Corneliussen, C.M. Costello et al., Genetic variation in DLG5 is associated with inflammatory bowel disease, Nat Genet 36(5) (2004), 476-480.
13. V.D. Peltekova, R.F. Wintle, L.A. Rubin et al., Functional variants of OCTN cation transporter genes are associated with Crohn disease, Nat Genet 36(5) (2004), 471-475.
14. K. Yamazaki, D. McGovern, J. Ragoussis et al., Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease, Human Molecular Genetics 14(22) (2005), 3499-3506.
15. R.H. Duerr, K.D. Taylor, S.R. Brant, J.D. Rioux, M.J. Silvernerg et al., A genome-wide association study identifies IL23R as an inflammatory bowel disease gene, Sciencexpress 26 (October 2006), 1-4.
16. J. Hampe, A. Franke, P. Rosenstiel et al., A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1, Nature Genetics 39(2) (2007), 207-211. (Pubitemid 46184351)
17. J.D. Rioux, R.J. Xavier, K.D. Taylor et al., Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis, Nature Genetics 39(5) (2007), 596-604.
18. C. Libioulle, E. Louis, S. Hansoul et al., Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4, PLoS Genetics 3(4) (2007), e58.
19. Wellcome Trust Case Control C. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.[see comment], Nature 447(7145) (2007), 661-678.
20. M. Parkes, J.C. Barrett, N.J. Prescott et al., Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility.[see comment], Nature Genetics 39(7) (2007), 830-832.
21. L. Gonzalez-Mariscal, A. Betanzos and A. Avila-Flores, MAGUK proteins: structure and role in the tight junction, Semin Cell Dev Biol 11(4) (2000), 315-1224
22. H. Nakamura, T. Sudo, H. Tsuiki et al., Identification of a novel human homolog of the Drosophila dlg, P-dlg, specifically expressed in the gland tissues and interacting with p55, FEBS Letters 433(1-2) (1998), 63-67.
23. S. Purmonen, T.M. Ahola, P. Pennanen et al., HDLG5/KIAA 0583, encoding a MAGUK-family protein, is a primary progesterone target gene in breast cancer cells, International Journal of Cancer 102(1) (2002), 1-6.
24. M.J. Daly, A.V. Pearce, L. Farwell et al., Association of DLG5 R30Q variant with inflammatory bowel disease.[see comment], European Journal of Human Genetics 13(7) (2005), 835-839.
25. W.G. Newman, X. Gu, R.F. Wintle et al., DLG5 variants contribute to Crohn disease risk in a Canadian population, Human Mutation 27(4) (2006), 353-358.
26. F. Friedrichs, S. Brescianini, V. Annese et al., Evidence of transmission ratio distortion of DLG5 R30Q variant in general and implication of an association with Crohn disease in men, Human Genetics 119(3) (2006), 305-311.
27. F. Friedrichs and M. Stoll, Role of discs large homolog 5, World Journal of Gastroenterology 12(23) (2006), 3651-3656.
28. S. Vermeire, M. Pierik, T. Hlavaty et al., Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD, Gastroenterology 129(6) (2005), 1845-1853.
29. P.L. Lakatos, S. Fischer, K. Claes et al., DLG5 R30Q is not associated with IBD in Hungarian IBD patients but predicts clinical response to steroids in Crohn's disease, Inflammatory Bowel Diseases 12(5) (2006), 362-368.
30. A. Ferraris, B. Torres, D. Knafelz et al., Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and earlyonset inflammatory bowel diseases: an Italian multicentric study, Inflammatory Bowel Diseases 12(5) (2006), 355-361.
31. C. Buning, L. Geerdts, T. Fiedler et al., DLG5 variants in inflammatory bowel disease, American Journal of Gastroenterology 101(4) (2006), 786-792.
32. H.P. Torok, J. Glas, L. Tonenchi et al., Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.[see comment], Gut 54(10) (2005), 1421-1427.
33. M. Tremelling, S. Waller, F. Bredin et al., Genetic variants in TNF-alpha but not DLG5 are associated with inflammatory bowel disease in a large United Kingdom cohort, Inflammatory Bowel Diseases 12(3) (2006), 178-184.
34. C.L. Noble, E.R. Nimmo, H. Drummond et al., The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease, Gastroenterology 129(6) (2005), 1854-1864.
35. B.L. Browning, M.L. Barclay, S.A. Bingham et al., Genderstratified analysis of DLG5 R30Q in 4707 Crohn's disease patients and 4973 controls from 12 Caucasian cohorts, JMG Online first, published on august 13, 2007 as 101136/ jmg2007050773 2007.
36. B.L. Browning, C. Huebner, I. Petermann et al., Association of DLG5 variants with inflammatory bowel disease in the New Zealand Caucasian population and meta-analysis of the DLG5 R30Q variant, Inflammatory Bowel Diseases 13(9) (2007), 1069-1076.
37. V. Biank, F. Friedrichs, U. Babusukumar et al., DLG5 R30Q variant is a female-specific protective factor in pediatric onset Crohn's disease, American Journal of Gastroenterology 102(2) (2007), 391-398.
38. H.M. Oh, J.M. Oh, S.C. Choi et al., An efficient method for the rapid establishment of Epstein-Barr virus immortalization of human B lymphocytes. [see comment], Cell Proliferation 36(4) (2003), 191-197.
39. Z. Lin, X. Cui and H. Li, Multiplex genotype determination at a large number of gene loci, Proc Natl Acad Sci USA 93(6) (1996), 2582-2587.
40. F.M. De la Vega, K.D. Lazaruk, M.D. Rhodes et al., Assessment of two flexible and compatible SNP genotyping platforms: TaqMan SNP Genotyping Assays and the SNPlex Genotyping System, Mutation Research 573(1-2) (2005), 111-135.
41. A.R. Tobler, S. Short, M.R. Andersen et al., The SNPlex genotyping system: a flexible and scalable platform for SNP genotyping, Journal of Biomolecular Techniques: JBT 16(4) (2005), 398-406.
42. wa.K. Zhang and A. Walter, Genetic factors in the etiology and potential management of inflammatory bowel disease, Seminars in colon and rectal Surgery 12(1) (2001), 2-8.
43. W. Koltun, W. Zhang, J. Thompson, M. Boyer, E. Galka and L. Poritz, Increased presence of NOD2 mutations in patients from a familial inflammatory bowel disease registry, Tripartite Colorectal Meeting, dublin, Ireland, 2005.
44. S.A. Fisher, J. Hampe, A.J. Macpherson et al., Sex stratification of an inflammatory bowel disease genome search shows male-specific linkage to the HLA region of chromosome 6, European Journal of Human Genetics 10(4) (2002), 259-265.